A class of compounds is disclosed, comprising sulphonamido-substituted bridged bicycloalkyl structures. The compounds are inhibitors of gamma-secretase, and hence are useful in the treatment of and/or prevention of Alzheimer's disease.
[EN] ENANTIOSELECTIVE SYNTHESIS OF 13-OXOTRICYCLO[8.2.1.0 3,8]TRIDECA-3(8),4,6-TRIENE-5-CARBOXYLATES<br/>[FR] SYNTHÈSE ÉNANTIOSÉLECTIVE DE CARBOXYLATES 13-OXOTRICYCLO[8.2.1.0 3,8]TRIDECA-3(8),4,6-TRIENE-5
申请人:MERCK SHARP & DOHME
公开号:WO2006018663A1
公开(公告)日:2006-02-23
An enantioselective route to compounds of formula (I) is disclosed. The compounds of formula (I) are key intermediates in the synthesis of compounds useful in treatment of Alzheimer's disease.
Compounds of Formula (I): inhibit the processing of APP by gamma-secretase, and hence are useful for treatment or prevention of Alzheimer's disease.
式(I)的化合物抑制γ-分泌酶对APP的加工,因此对于治疗或预防阿尔茨海默病有用。
Sulfamides as gamma-secretase inhibitors
申请人:——
公开号:US20040049038A1
公开(公告)日:2004-03-11
Novel sulfamides of formula (1) are disclosed. The compounds exert an inhibitory action on the processing of APP by gamma-secretase, and are therefore useful in the treatment or prevention of Alzheimer's disease.